Zhejiang Anglikang Pharmaceuticals Co., Ltd. logo

Zhejiang Anglikang Pharmaceuticals Co., Ltd. (002940)

Market Closed
10 Aug, 06:57
XSHE XSHE
¥
26. 60
+0.22
+0.834%
¥
7.61B Market Cap
- P/E Ratio
0.4% Div Yield
15.03M Volume
- Eps
¥ 26.38
Previous Close
Add Transaction
Day Range
25.59 27.28
Year Range
23.11 58.93
Want to track 002940 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

002940 closed yesterday higher at ¥26.6, an increase of 0.834% from Friday's close, completing a monthly increase of 0.9105% or ¥0.24. Over the past 12 months, 002940 stock lost -20.6444%.
002940 pays dividends to its shareholders, with the most recent payment made on Jun 22, 2026. The next estimated payment will be in In 4 months on Dec 22, 2026 for a total of ¥0.15.
The last earnings report, released on May 15, 2025, exceeded the consensus estimates by 0.0808%. On average, the company has surpassed earnings expectations by 0.0437%, based on the last three reports.
Zhejiang Anglikang Pharmaceuticals Co., Ltd. has completed 2 stock splits, with the recent split occurring on May 19, 2023.
The company's stock is traded on one exchange.

002940 Chart

People also search for

Dr Corp Ltd.
¥ 23.35
-2.4237%
Sunvim Group Co., Ltd.
¥ 11.72
-3.3003%
Tibet Gaozheng Explosive Co., Ltd.
¥ 58.61
-1.6281%
Innovative Medical Management Co., Ltd.
¥ 21.24
-3.1022%
Henan Liliang Diamond Co., Ltd.
¥ 59.21
-1.366%

Zhejiang Anglikang Pharmaceuticals Co., Ltd. (002940) FAQ

What is the stock price today?

The current price is ¥26.60.

On which exchange is it traded?

Zhejiang Anglikang Pharmaceuticals Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 002940.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.4%.

What is its market cap?

As of today, the market cap is 7.61B.

Has Zhejiang Anglikang Pharmaceuticals Co., Ltd. ever had a stock split?

Zhejiang Anglikang Pharmaceuticals Co., Ltd. had 2 splits and the recent split was on May 19, 2023.

Zhejiang Anglikang Pharmaceuticals Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Guo Gang Zheng CEO
XSHE Exchange
CNE100003GC2 ISIN
CN Country
1,275 Employees
22 Jun 2026 Last Dividend
19 May 2023 Last Split
- IPO Date

Overview

Zhejiang AngLiKang Pharmaceutical CO.,LTD. is a reputable pharmaceutical company based in Shengzhou, China. Since its foundation in 2001, the company has actively engaged in the manufacture of Active Pharmaceutical Ingredients (APIs) and a wide range of pharmaceutical preparations. Specializing in oral cephalosporins, the company has expanded its expertise to cover vital healthcare areas such as cardiovascular and kidney diseases. The breadth of its commitment to improving health care is evident through its diverse product offerings targeting critical therapeutic areas including anti-infection, antihypertensive, digestive, central nervous system diseases, and respiratory preparations.

Products and Services

  • Oral Cephalosporins

    Specialized in the development and manufacturing of cephalosporin-based antibiotics, Zhejiang AngLiKang Pharmaceutical provides a broad spectrum of oral cephalosporin medications. These are critical in treating infections caused by bacteria resistant to other antibiotics, showcasing the company's commitment to combating antimicrobial resistance.

  • Cardiovascular Disease Preparations

    The company offers an extensive range of products for the treatment and management of cardiovascular diseases. These preparations are formulated to address a wide variety of conditions related to heart and blood vessels, emphasizing the company's role in supporting heart health.

  • Kidney Disease Treatments

    Zhejiang AngLiKang Pharmaceutical extends its pharmaceutical expertise to include treatments for kidney diseases. These products are designed to help manage and treat various kidney conditions, underscoring the company's dedication to contributing to nephrology.

  • Anti-infection

    In addition to oral cephalosporins, the company produces a comprehensive array of products aimed at preventing and treating infectious diseases. Through these products, Zhejiang AngLiKang Pharmaceutical reinforces its commitment to safeguarding public health against infections.

  • Antihypertensive Medications

    Addressing the global challenge of hypertension, the company provides a variety of antihypertensive medications. These products are crucial for managing high blood pressure, further indicating the company's involvement in promoting cardiovascular health.

  • Digestive System Treatments

    Focused on enhancing gastrointestinal health, Zhejiang AngLiKang Pharmaceutical offers treatments for a range of digestive system conditions. These medications help in improving digestive health and quality of life for individuals suffering from various gastrointestinal disorders.

  • Central Nervous System Diseases

    Understanding the impact of central nervous system disorders, the company provides medications aimed at treating and managing these conditions. This aspect of their product line demonstrates Zhejiang AngLiKang Pharmaceutical’s dedication to addressing mental health and neurological diseases.

  • Respiratory Preparations

    The respiratory system is another primary focus for Zhejiang AngLiKang Pharmaceutical. The company offers a selection of preparations for respiratory conditions, aiding in the treatment and management of diseases affecting the respiratory tract.

Contact Information

Address: No. 1000, North of Shengzhou Avenue, Shengzhou, China, 312400
Phone: 86 575 8312 3228